Biomarker Strategies, LLC

Company Information
Address 15601 CRABBS BRANCH WAY
DERWOOD, MD, 20855-2734

http://www.biomarkerstrategies.com/

Information

DUNS: 948737700

# of Employees: 12


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Development of a companion diagnostic to predict response to cetuximab in patients with head and neck squamous cell carcinoma

    Amount: $299,340.00

    ABSTRACT Head and neck squamous cell carcinoma HNSCC is the world s th leading cause of cancer accounting for of cancer mortality For many other cancers molecular characterization has led to ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  2. PathMAP NSCLC: A functional companion diagnostic test to predict optimal therapy for patients with non-small cell lung cancer.

    Amount: $1,982,173.00

    Lung cancerLCis the leading cause of cancer death in the US with an estimateddeaths inNonsmall cell LC is the predominant category of the diseaseNSCLCMolecular characterization of tumors has shifted t ...

    SBIRPhase II2017Department of Health and Human Services
  3. IGF OT IGF SBIR PHASE I TOPIC A NOVEL PREDICTIVE TEST FOR RESPONSE TO IMMUNOTHERAPIES FOR PATIENTS WITH NON SMALL CELL LUNG CANCER POP

    Amount: $223,063.00

    Significant advances in the development of immune checkpoint inhibitors have yielded durable responses in Non Small Cell Lung Cancer NSCLC the most common form of lung cancer Unfortunately many p ...

    SBIRPhase I2016Department of Health and Human Services
  4. PathMAP NSCLC: A functional companion diagnostic test to predict optimal therapy for patients with non-small cell lung cancer.

    Amount: $299,876.00

    DESCRIPTION provided by applicant Lung cancer LC is the leading cause of cancer death in the US with an estimated deaths in Non small cell LC is the predominant category of the dis ...

    SBIRPhase I2015Department of Health and Human Services National Institutes of Health
  5. TOPIC 277 PHASE II; COMPANION DIAGNOSTICS: PREDICTIVE and PROGNOSTIC TESTS ENABLING

    Amount: $1,498,569.00

    Not Available

    SBIRPhase II2013Department of Health and Human Services
  6. TAS::75 0849::TAS SBIR TOPIC 257, PHASE II, EXERCISE OPTION YEAR 2

    Amount: $1,037,945.00

    Fine Needle Aspiration Biopsy (FNAB) is a minimally-invasive method for sampling human tumors that is widely used in the United States. Historically, FNAB samples have provided adequate material for m ...

    SBIRPhase I2011Department of Health and Human Services
  7. TAS::75 0849::TAS SBIR TOPIC 277- PHASE I SNAPMAPTM: A FUNCTIONAL COMPANION DIAGNOSTIC TEST

    Amount: $192,786.00

    Most of the currently utilized predictive biomarkers for therapeutic decision-making provide information about the presence or absence of the drug target, but reveal little about the functional circui ...

    SBIRPhase I2011Department of Health and Human Services
  8. SBIR TOPIC 257, INSTRUMENTS AND DEVICES THAT PRESERVE MOLECULAR PROFILES IN TUMOR

    Amount: $254,810.00

    SBIRPhase I2009Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government